WARREN, N.J., Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- Tevogen Bio ( "Tevogen Bio Holdings Inc." or "Company" ) TVGN, a clinical-stage specialty immunotherapy biotech company, today issued a statement from its Founder and CEO, Nobel Peace Prize nominee Dr. Ryan Saadi, regarding broader implications ...

Lottery.com plans global expansion with new platform acquisition. The $1.5 million acquisition will optimize operations and scalability. Get real-time earnings alerts before the market moves and access expert analysis that uncovers hidden opportunities in the post-earnings chaos.

NEW YORK, Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. ( "Pacira" or the "Company" ) PCRX for violations of the federal securities ...

NEW YORK, Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. ( "FTAI" or the "Company" ) FTAI for violations of the federal securities laws on ...

BENSALEM, Pa., Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

CESUR Mining, a global leader in cloud mining, is proud to announce the expansion of its services to make cloud mining more convenient, efficient, and profitable for users around the world. Providing users with a seamless cloud mining experience

LOS ANGELES, Feb. 14, 2025 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP reminds investors of the upcoming April 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Monolithic Power Systems Inc. ( "Monolithic" ...

Investors with a lot of money to spend have taken a bullish stance on Novo Nordisk NVO. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Investors with a lot of money to spend have taken a bullish stance on AppLovin APP. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Order intake of €466 million, resulting in a soft backlog of €654 million, marking a 20% year-on-year increase Additional embedded options of €301 million, providing further visibility Revenue of €352.4 million, above guidance, representing top line growth of 61.1%